Indication
For active immunisation of pigs against enterotoxigenic F4-positive Escherichia coli in order to: reduce the incidence of moderate to severe post-weaning Escherichia coli diarrhoea (PWD) in pigs; reduce the colonisation of the ileum and faecal shedding of enterotoxigenic F4-positive Escherichia coli from infected pigs.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Free account required
Ask Prognia AI about Coliprotec F4 — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.